Pulmonary Edema Market [2021-2031] - Size, Share
The Pulmonary Edema Market is expected to register a CAGR of 8.4% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX million by 2031.
Pulmonary Edema Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By : Type ( Heart-related Pulmonary Edema, Non-heart-related pulmonary Edema ); Type of Diagnosis ( Chest X-Ray, Pulse Oximetry, Blood Test, Imaging and others ); Treatment ( Preload Reducers, After Load Reducers, Heart Medication, Morphine, Suction Catheter, others ); End-User ( Hospitals, Clinics, Diagnostic Centers, Retail Pharmacies, others ), and Geography (North America, Europe, Asia Pacific, and South and Central America)
Purpose of the ReportThe report Pulmonary Edema Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Pulmonary Edema Market Segmentation
Type- Heart-related Pulmonary Edema
- Non-heart-related pulmonary Edema
- Chest X-Ray
- Pulse Oximetry
- Blood Test
- Imaging and others
- Preload Reducers
- After Load Reducers
- Heart Medication
- Morphine
- Suction Catheter
- others
- Hospitals
- Clinics
- Diagnostic Centers
- Retail Pharmacies
- others
- Hospitals
- Clinics
- Diagnostic Centers
- Retail Pharmacies
- others
Strategic Insights
Pulmonary Edema Market Growth Drivers- Increasing incidence of Breast Cancer: Globalization and growing economy has further exacerbated breast cancer incidence in developing (64% to 95) and developed (32% to 56%) nations. Breast cancer is the most common cancer in India, accounting for 28.2% of all female cancers, with an estimated 216,108 cases by 2022
- Alcohol Consumption Among Women is Rising: In India, where alcohol consumption among women is rising, it is crucial to be mindful of this risk. Being overweight or obese, especially after menopause, increases the risk of breast cancer. Breast cancer is the 2nd most common cancer worldwide. It is the number one cancer in women.
- Technologically Advancements- Various technological advancements that detects cancer at a early stage is promoting growth. These include improvements on the standard techniques (mammography, ultrasound, and MRI) as well as new platforms for breast imaging developed from body imaging tools, which include CT and radionuclide breast imaging.
- Ionizing Breast Imaging Technologies: Medical exposures to radiation as well as large-scale disasters such as exposures from the atomic bomb in Japan has demonstrated that radiation can cause breast cancer. Ionizing radiation is any form of radiation with enough energy to alter an atom, such as X-rays or nuclear energy
- Inclusion of Artificial Intelligence : Theranostics is a currently underdeveloped nuclear medicine therapy but will become a vital tool in the future arsenal of breast radiologists. AI-assisted imaging diagnosis provides a promising perspective of a more accurate and high-efficient diagnostic model for breast cancer. The AI-system is trained on thousands of de-identified mammograms.
- Digital breast tomosynthesis: Digital breast tomosynthesis screening exam, which is also known as 3D mammography, has become a best practice in women's health for breast cancer-detecting technology. Breast tomosynthesis differs from traditional mammograms in how the image of the breast is obtained and viewed.
- Growth Potential in Emerging Nations: Countries such as India, China, Brazil, Russia, South Korea, and Turkey have huge population base and that will spur the growth of diagnostic imaging devices market. Annual mammography and MRI screening are recommended starting at 30 years of age for women with BRCA germline mutation in China.
- Initiatives taken for Breast Cancer: UICC's Breast Cancer programme aims to support and strengthen the capacity of key breast cancer actors to increase their impact, with a particular focus on low- and middle-income countries, and support the achievement of the goals of the GBCI. The Global Breast Cancer Initiative, established by WHO in 2021, will provide guidance to governments on health systems strengthening for breast cancer.
- Breast Cancer Fundings: Komen awards grants to support cutting-edge breast cancer research that will provide the greatest benefit to patients. The mission of the Breast Cancer Research Foundation is to prevent and cure breast cancer by advancing the world's most promising breast cancer research
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Pulmonary Edema Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Pulmonary Edema Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
In Europe, the UK held the second largest share in 2023.
Asia pacific region is expected to witness the highest growth during the forecast period
North America held the largest share in 2023 and is expected to retain its dominance during the forecast period
Growth Potential in Emerging Nations
The Pulmonary Edema Market is estimated to witness a CAGR of 8.4% from 2023 to 2031
Increasing incidence of Breast Cancer
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pulmonary Edema Market - By Type
1.3.2 Pulmonary Edema Market - By Type of Diagnosis
1.3.3 Pulmonary Edema Market - By Treatment
1.3.4 Pulmonary Edema Market - By End-User
1.3.5 Pulmonary Edema Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PULMONARY EDEMA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PULMONARY EDEMA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PULMONARY EDEMA MARKET - GLOBAL MARKET ANALYSIS
6.1. PULMONARY EDEMA - GLOBAL MARKET OVERVIEW
6.2. PULMONARY EDEMA - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PULMONARY EDEMA MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. HEART-RELATED PULMONARY EDEMA
7.3.1. Overview
7.3.2. Heart-related Pulmonary Edema Market Forecast and Analysis
7.4. NON-HEART-RELATED PULMONARY EDEMA
7.4.1. Overview
7.4.2. Non-heart-related pulmonary Edema Market Forecast and Analysis
8. PULMONARY EDEMA MARKET - REVENUE AND FORECASTS TO 2028 - TYPE OF DIAGNOSIS
8.1. OVERVIEW
8.2. TYPE OF DIAGNOSIS MARKET FORECASTS AND ANALYSIS
8.3. CHEST X-RAY
8.3.1. Overview
8.3.2. Chest X-Ray Market Forecast and Analysis
8.4. PULSE OXIMETRY
8.4.1. Overview
8.4.2. Pulse Oximetry Market Forecast and Analysis
8.5. BLOOD TEST
8.5.1. Overview
8.5.2. Blood Test Market Forecast and Analysis
8.6. IMAGING AND OTHERS
8.6.1. Overview
8.6.2. Imaging and others Market Forecast and Analysis
9. PULMONARY EDEMA MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. PRELOAD REDUCERS
9.3.1. Overview
9.3.2. Preload Reducers Market Forecast and Analysis
9.4. AFTER LOAD REDUCERS
9.4.1. Overview
9.4.2. After Load Reducers Market Forecast and Analysis
9.5. HEART MEDICATION
9.5.1. Overview
9.5.2. Heart Medication Market Forecast and Analysis
9.6. MORPHINE
9.6.1. Overview
9.6.2. Morphine Market Forecast and Analysis
9.7. SUCTION CATHETER
9.7.1. Overview
9.7.2. Suction Catheter Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. others Market Forecast and Analysis
10. PULMONARY EDEMA MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
10.1. OVERVIEW
10.2. END-USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. CLINICS
10.4.1. Overview
10.4.2. Clinics Market Forecast and Analysis
10.5. DIAGNOSTIC CENTERS
10.5.1. Overview
10.5.2. Diagnostic Centers Market Forecast and Analysis
10.6. RETAIL PHARMACIES
10.6.1. Overview
10.6.2. Retail Pharmacies Market Forecast and Analysis
10.7. OTHERS
10.7.1. Overview
10.7.2. others Market Forecast and Analysis
11. PULMONARY EDEMA MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Pulmonary Edema Market Overview
11.1.2 North America Pulmonary Edema Market Forecasts and Analysis
11.1.3 North America Pulmonary Edema Market Forecasts and Analysis - By Type
11.1.4 North America Pulmonary Edema Market Forecasts and Analysis - By Type of Diagnosis
11.1.5 North America Pulmonary Edema Market Forecasts and Analysis - By Treatment
11.1.6 North America Pulmonary Edema Market Forecasts and Analysis - By End-User
11.1.7 North America Pulmonary Edema Market Forecasts and Analysis - By Countries
11.1.7.1 United States Pulmonary Edema Market
11.1.7.1.1 United States Pulmonary Edema Market by Type
11.1.7.1.2 United States Pulmonary Edema Market by Type of Diagnosis
11.1.7.1.3 United States Pulmonary Edema Market by Treatment
11.1.7.1.4 United States Pulmonary Edema Market by End-User
11.1.7.2 Canada Pulmonary Edema Market
11.1.7.2.1 Canada Pulmonary Edema Market by Type
11.1.7.2.2 Canada Pulmonary Edema Market by Type of Diagnosis
11.1.7.2.3 Canada Pulmonary Edema Market by Treatment
11.1.7.2.4 Canada Pulmonary Edema Market by End-User
11.1.7.3 Mexico Pulmonary Edema Market
11.1.7.3.1 Mexico Pulmonary Edema Market by Type
11.1.7.3.2 Mexico Pulmonary Edema Market by Type of Diagnosis
11.1.7.3.3 Mexico Pulmonary Edema Market by Treatment
11.1.7.3.4 Mexico Pulmonary Edema Market by End-User
11.2. EUROPE
11.2.1 Europe Pulmonary Edema Market Overview
11.2.2 Europe Pulmonary Edema Market Forecasts and Analysis
11.2.3 Europe Pulmonary Edema Market Forecasts and Analysis - By Type
11.2.4 Europe Pulmonary Edema Market Forecasts and Analysis - By Type of Diagnosis
11.2.5 Europe Pulmonary Edema Market Forecasts and Analysis - By Treatment
11.2.6 Europe Pulmonary Edema Market Forecasts and Analysis - By End-User
11.2.7 Europe Pulmonary Edema Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Pulmonary Edema Market
11.2.7.1.1 Germany Pulmonary Edema Market by Type
11.2.7.1.2 Germany Pulmonary Edema Market by Type of Diagnosis
11.2.7.1.3 Germany Pulmonary Edema Market by Treatment
11.2.7.1.4 Germany Pulmonary Edema Market by End-User
11.2.7.2 France Pulmonary Edema Market
11.2.7.2.1 France Pulmonary Edema Market by Type
11.2.7.2.2 France Pulmonary Edema Market by Type of Diagnosis
11.2.7.2.3 France Pulmonary Edema Market by Treatment
11.2.7.2.4 France Pulmonary Edema Market by End-User
11.2.7.3 Italy Pulmonary Edema Market
11.2.7.3.1 Italy Pulmonary Edema Market by Type
11.2.7.3.2 Italy Pulmonary Edema Market by Type of Diagnosis
11.2.7.3.3 Italy Pulmonary Edema Market by Treatment
11.2.7.3.4 Italy Pulmonary Edema Market by End-User
11.2.7.4 Spain Pulmonary Edema Market
11.2.7.4.1 Spain Pulmonary Edema Market by Type
11.2.7.4.2 Spain Pulmonary Edema Market by Type of Diagnosis
11.2.7.4.3 Spain Pulmonary Edema Market by Treatment
11.2.7.4.4 Spain Pulmonary Edema Market by End-User
11.2.7.5 United Kingdom Pulmonary Edema Market
11.2.7.5.1 United Kingdom Pulmonary Edema Market by Type
11.2.7.5.2 United Kingdom Pulmonary Edema Market by Type of Diagnosis
11.2.7.5.3 United Kingdom Pulmonary Edema Market by Treatment
11.2.7.5.4 United Kingdom Pulmonary Edema Market by End-User
11.2.7.6 Rest of Europe Pulmonary Edema Market
11.2.7.6.1 Rest of Europe Pulmonary Edema Market by Type
11.2.7.6.2 Rest of Europe Pulmonary Edema Market by Type of Diagnosis
11.2.7.6.3 Rest of Europe Pulmonary Edema Market by Treatment
11.2.7.6.4 Rest of Europe Pulmonary Edema Market by End-User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Pulmonary Edema Market Overview
11.3.2 Asia-Pacific Pulmonary Edema Market Forecasts and Analysis
11.3.3 Asia-Pacific Pulmonary Edema Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Pulmonary Edema Market Forecasts and Analysis - By Type of Diagnosis
11.3.5 Asia-Pacific Pulmonary Edema Market Forecasts and Analysis - By Treatment
11.3.6 Asia-Pacific Pulmonary Edema Market Forecasts and Analysis - By End-User
11.3.7 Asia-Pacific Pulmonary Edema Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Pulmonary Edema Market
11.3.7.1.1 Australia Pulmonary Edema Market by Type
11.3.7.1.2 Australia Pulmonary Edema Market by Type of Diagnosis
11.3.7.1.3 Australia Pulmonary Edema Market by Treatment
11.3.7.1.4 Australia Pulmonary Edema Market by End-User
11.3.7.2 China Pulmonary Edema Market
11.3.7.2.1 China Pulmonary Edema Market by Type
11.3.7.2.2 China Pulmonary Edema Market by Type of Diagnosis
11.3.7.2.3 China Pulmonary Edema Market by Treatment
11.3.7.2.4 China Pulmonary Edema Market by End-User
11.3.7.3 India Pulmonary Edema Market
11.3.7.3.1 India Pulmonary Edema Market by Type
11.3.7.3.2 India Pulmonary Edema Market by Type of Diagnosis
11.3.7.3.3 India Pulmonary Edema Market by Treatment
11.3.7.3.4 India Pulmonary Edema Market by End-User
11.3.7.4 Japan Pulmonary Edema Market
11.3.7.4.1 Japan Pulmonary Edema Market by Type
11.3.7.4.2 Japan Pulmonary Edema Market by Type of Diagnosis
11.3.7.4.3 Japan Pulmonary Edema Market by Treatment
11.3.7.4.4 Japan Pulmonary Edema Market by End-User
11.3.7.5 South Korea Pulmonary Edema Market
11.3.7.5.1 South Korea Pulmonary Edema Market by Type
11.3.7.5.2 South Korea Pulmonary Edema Market by Type of Diagnosis
11.3.7.5.3 South Korea Pulmonary Edema Market by Treatment
11.3.7.5.4 South Korea Pulmonary Edema Market by End-User
11.3.7.6 Rest of Asia-Pacific Pulmonary Edema Market
11.3.7.6.1 Rest of Asia-Pacific Pulmonary Edema Market by Type
11.3.7.6.2 Rest of Asia-Pacific Pulmonary Edema Market by Type of Diagnosis
11.3.7.6.3 Rest of Asia-Pacific Pulmonary Edema Market by Treatment
11.3.7.6.4 Rest of Asia-Pacific Pulmonary Edema Market by End-User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Pulmonary Edema Market Overview
11.4.2 Middle East and Africa Pulmonary Edema Market Forecasts and Analysis
11.4.3 Middle East and Africa Pulmonary Edema Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Pulmonary Edema Market Forecasts and Analysis - By Type of Diagnosis
11.4.5 Middle East and Africa Pulmonary Edema Market Forecasts and Analysis - By Treatment
11.4.6 Middle East and Africa Pulmonary Edema Market Forecasts and Analysis - By End-User
11.4.7 Middle East and Africa Pulmonary Edema Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Pulmonary Edema Market
11.4.7.1.1 South Africa Pulmonary Edema Market by Type
11.4.7.1.2 South Africa Pulmonary Edema Market by Type of Diagnosis
11.4.7.1.3 South Africa Pulmonary Edema Market by Treatment
11.4.7.1.4 South Africa Pulmonary Edema Market by End-User
11.4.7.2 Saudi Arabia Pulmonary Edema Market
11.4.7.2.1 Saudi Arabia Pulmonary Edema Market by Type
11.4.7.2.2 Saudi Arabia Pulmonary Edema Market by Type of Diagnosis
11.4.7.2.3 Saudi Arabia Pulmonary Edema Market by Treatment
11.4.7.2.4 Saudi Arabia Pulmonary Edema Market by End-User
11.4.7.3 U.A.E Pulmonary Edema Market
11.4.7.3.1 U.A.E Pulmonary Edema Market by Type
11.4.7.3.2 U.A.E Pulmonary Edema Market by Type of Diagnosis
11.4.7.3.3 U.A.E Pulmonary Edema Market by Treatment
11.4.7.3.4 U.A.E Pulmonary Edema Market by End-User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Pulmonary Edema Market Overview
11.5.2 South and Central America Pulmonary Edema Market Forecasts and Analysis
11.5.3 South and Central America Pulmonary Edema Market Forecasts and Analysis - By Type
11.5.4 South and Central America Pulmonary Edema Market Forecasts and Analysis - By Type of Diagnosis
11.5.5 South and Central America Pulmonary Edema Market Forecasts and Analysis - By Treatment
11.5.6 South and Central America Pulmonary Edema Market Forecasts and Analysis - By End-User
11.5.7 South and Central America Pulmonary Edema Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Pulmonary Edema Market
11.5.7.1.1 Brazil Pulmonary Edema Market by Type
11.5.7.1.2 Brazil Pulmonary Edema Market by Type of Diagnosis
11.5.7.1.3 Brazil Pulmonary Edema Market by Treatment
11.5.7.1.4 Brazil Pulmonary Edema Market by End-User
11.5.7.2 Argentina Pulmonary Edema Market
11.5.7.2.1 Argentina Pulmonary Edema Market by Type
11.5.7.2.2 Argentina Pulmonary Edema Market by Type of Diagnosis
11.5.7.2.3 Argentina Pulmonary Edema Market by Treatment
11.5.7.2.4 Argentina Pulmonary Edema Market by End-User
11.5.7.3 Rest of South and Central America Pulmonary Edema Market
11.5.7.3.1 Rest of South and Central America Pulmonary Edema Market by Type
11.5.7.3.2 Rest of South and Central America Pulmonary Edema Market by Type of Diagnosis
11.5.7.3.3 Rest of South and Central America Pulmonary Edema Market by Treatment
11.5.7.3.4 Rest of South and Central America Pulmonary Edema Market by End-User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PULMONARY EDEMA MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. PULMONARY EDEMA MARKET, KEY COMPANY PROFILES
14.1. PFIZER INC.,
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ARGON MEDICAL
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. EDWARD LIFESCIENCES CORPORATION
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BD
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. LUPIN PHARMACEUTICALS INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. NOVARTIS AG, GILEAD SCIENCES INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. MERCK AND CO
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. JAZZ PHARMACEUTICALS PLC
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. SAGE THERAPEUTICS
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Pfizer Inc.,
2. Argon Medical
3. Edward Lifesciences Corporation
4. BD
5. Lupin Pharmaceuticals Inc.
6. Novartis AG
7. Gilead Sciences Inc.
8. Merck & Co
9. Jazz Pharmaceuticals Plc
10. Sage Therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For